Literature DB >> 19524870

Induction of chemokine expression by adiponectin in vitro is isoform dependent.

Huijuan Song1, James Chan, Brad H Rovin.   

Abstract

Adiponectin is reported to have both proinflammatory and anti-inflammatory effects. Because adiponectin circulates in isoforms of various sizes and some responses to adiponectin are isoform dependent, it was postulated that the proinflammatory effects of adiponectin may be isoform specific. To test this theory, peripheral blood mononuclear cells (PBMCs), microvascular endothelial cells (MVECs), and human glomerular mesangial cells (HMCs) were treated with high-molecular-weight (HMW) or low-molecular-weight (LMW) recombinant human adiponectin, and chemokine production was measured. The PBMCs were isolated from healthy volunteers by density gradient centrifugation of ethylenediaminetetraacetic acid (EDTA) anticoagulated whole blood through endotoxin-free Ficoll (General Electric Healthcare Bio-Sciences, Uppsala, Sweden). The MVECs were of dermal origin, and the HMCs were isolated from kidneys not suitable for transplantation. Overnight (16 h) incubation with HMW adiponectin (0.01-1 microg/mL for PBMCs; 5-20 microg/mL for MVECs and HMCs) induced a dose-dependent increase in production of monocyte chemoattractant protein-1 and interleukin-8 by PBMCs and MVECs, but it had no effect on HMC chemokine production (n=3-5). LMW adiponectin at the same concentrations did not induce chemokine production in any of the cell types tested, and it did not block cytokine-induced chemokine production by PBMCs or MVECs (n=3-5). These in vitro data suggested that the HMW adiponectin isoform is proinflammatory. To examine the possibility of a relationship between HMW adiponectin and inflammation in vivo, the urine of patients with systemic lupus erythematosus (SLE) and kidney involvement, which was shown previously to contain immunoreactive adiponectin, was examined for the presence of specific adiponectin isoforms by nondenaturing gel electrophoresis. HMW adiponectin was found in the urine of patients with active lupus nephritis. Therefore, HMW adiponectin may contribute to the renal inflammation of SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524870      PMCID: PMC2727280          DOI: 10.1016/j.trsl.2009.04.003

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  46 in total

1.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.

Authors:  A H Berg; T P Combs; X Du; M Brownlee; P E Scherer
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

2.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.

Authors:  N Ouchi; S Kihara; Y Arita; K Maeda; H Kuriyama; Y Okamoto; K Hotta; M Nishida; M Takahashi; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Circulation       Date:  1999 Dec 21-28       Impact factor: 29.690

Review 3.  Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.

Authors:  B Viollet; R Mounier; J Leclerc; A Yazigi; M Foretz; F Andreelli
Journal:  Diabetes Metab       Date:  2007-11-07       Impact factor: 6.041

Review 4.  The chemokine network in systemic lupus erythematous nephritis.

Authors:  Brad H Rovin
Journal:  Front Biosci       Date:  2008-01-01

Review 5.  MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.

Authors:  G H Tesch
Journal:  Am J Physiol Renal Physiol       Date:  2008-02-13

Review 6.  Adiponectin: an update.

Authors:  M Guerre-Millo
Journal:  Diabetes Metab       Date:  2008-02       Impact factor: 6.041

7.  Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin.

Authors:  Fred Haugen; Christian A Drevon
Journal:  Endocrinology       Date:  2007-08-16       Impact factor: 4.736

Review 8.  The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi; Naoto Kubota
Journal:  FEBS Lett       Date:  2007-12-03       Impact factor: 4.124

9.  Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice.

Authors:  J Fruebis; T S Tsao; S Javorschi; D Ebbets-Reed; M R Erickson; F T Yen; B E Bihain; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

10.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.

Authors:  T Yamauchi; J Kamon; H Waki; Y Terauchi; N Kubota; K Hara; Y Mori; T Ide; K Murakami; N Tsuboyama-Kasaoka; O Ezaki; Y Akanuma; O Gavrilova; C Vinson; M L Reitman; H Kagechika; K Shudo; M Yoda; Y Nakano; K Tobe; R Nagai; S Kimura; M Tomita; P Froguel; T Kadowaki
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

View more
  12 in total

1.  Resistin as a potential marker of renal disease in lupus nephritis.

Authors:  J Hutcheson; Y Ye; J Han; C Arriens; R Saxena; Q-Z Li; C Mohan; T Wu
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

2.  Modulation of lupus phenotype by adiponectin deficiency in autoimmune mouse models.

Authors:  Jennifer Parker; Hanni Menn-Josephy; Bari Laskow; Yukihiro Takemura; Tamar Aprahamian
Journal:  J Clin Immunol       Date:  2010-11-10       Impact factor: 8.317

3.  Adiponectin secreted by tubular renal cells during LPS exposure worsens the cellular inflammatory damage.

Authors:  Anna Perri; Donatella Vizza; Simona Lupinacci; Giuseppina Toteda; Francesca De Amicis; Francesca Leone; Paolo Gigliotti; Danilo Lofaro; Antonella La Russa; Renzo Bonofiglio
Journal:  J Nephrol       Date:  2015-07-28       Impact factor: 3.902

Review 4.  Emerging role of adipokines in systemic lupus erythematosus.

Authors:  Hong-Miao Li; Tian-Ping Zhang; Rui-Xue Leng; Xiang-Pei Li; Xiao-Mei Li; Hai-Rong Liu; Dong-Qing Ye; Hai-Feng Pan
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

5.  Suppression of adiponectin by aberrantly glycosylated IgA1 in glomerular mesangial cells in vitro and in vivo.

Authors:  Tatsuyuki Inoue; Hitoshi Sugiyama; Masashi Kitagawa; Keiichi Takiue; Hiroshi Morinaga; Ayu Ogawa; Yoko Kikumoto; Shinji Kitamura; Yohei Maeshima; Hirofumi Makino
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

6.  Adiponectin is a potential catabolic mediator in osteoarthritis cartilage.

Authors:  Eun Ha Kang; Yun Jong Lee; Tae Kyun Kim; Chong Bum Chang; Jin-Haeng Chung; Kichul Shin; Eun Young Lee; Eun Bong Lee; Yeong Wook Song
Journal:  Arthritis Res Ther       Date:  2010-12-31       Impact factor: 5.156

7.  Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus.

Authors:  S Torabinejad; R Mardani; Z Habibagahi; J Roozbeh; P Khajedehi; M Pakfetrat; M A Banihashemi; S J Banihashemi
Journal:  Indian J Nephrol       Date:  2012-01

Review 8.  Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases.

Authors:  Hyung Muk Choi; Hari Madhuri Doss; Kyoung Soo Kim
Journal:  Int J Mol Sci       Date:  2020-02-12       Impact factor: 5.923

Review 9.  The role of adipokines in connective tissue diseases.

Authors:  Robert Krysiak; Gabriela Handzlik-Orlik; Boguslaw Okopien
Journal:  Eur J Nutr       Date:  2012-05-15       Impact factor: 5.614

10.  Response to 'Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort'- authors' reply.

Authors:  Eric Toussirot; Gilles Dumoulin
Journal:  Arthritis Res Ther       Date:  2014-04-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.